ED Coding & Reimbursement Alert - 2005 Issue 38
PHARMACEUTICALS: GAO Outlines Skyrocketing Drug Price Pattern
Subscribe or sign in to view the full article.
Article Overview
This article reviews a Government Accountability Office report on prescription drug pricing trends, focusing on how prices changed over a four-year period and how those changes differed across categories of drugs and payer populations. It is relevant to healthcare providers, pharmacy professionals, coders working with pharmacy-related claims context, and policy readers who monitor drug cost trends and reimbursement pressures. The discussion centers on the general findings of the report and the pricing measures used, without getting into coding specifics.
Why This Topic Matters
Drug cost trends can affect dispensing, coverage, and reimbursement environments, especially when public and private programs track pharmacy spending differently. Understanding the scope of the GAO report helps readers decide whether the full article is relevant to pricing, benefits administration, or health policy work.
What You Will Learn
- What the GAO report examined
- Which drug pricing measures were compared
- How pricing trends differed across drug categories
- Why the report may matter to pharmacy and reimbursement stakeholders
Who Should Read This
- Pharmacists
- Healthcare administrators
- Medical coders
- Billing staff
- Health policy professionals
Subscribe or sign in to view the full article.
Quick, Current, Complete - www.findacode.com